A study using a Korean database found that COVID-19 infection raised long-term risks for various autoimmune and ...

Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at ...

Biotech stocks, including Regeneron, have seen significant declines due to regulatory and political uncertainty, presenting a potential buying opportunity as seller exhaustion nears. Regeneron's 40% ...

Bronte Capital, an investment management company, released its “Amalthea Fund” third-quarter 2024 investor letter. A copy of ...

The number of international students at Princeton has grown in recent years, but struggles with the American application ...

It takes a cracked mindset to name a cracked pot with no scientific training to head the agency that oversees 11 agencies ...

In a recent Regeneron survey, conducted by The Harris Poll in July and August 2024 among 100 U.S. adults 18+ who participated in a clinical trial in the past five years, nearly half (48%) reported ...

Finally, the number of opportunities in the biosimilars space is very high — there are more than 300 biologics in the market, ...

Treatment with metformin was associated with a reduction in asthma attacks among patients with asthma and type 2 diabetes, with additional reductions observed with the use of GLP-1 receptor agonists, ...

Here’s a stock picking tool you might not have thought about. It’s called the PEG ratio. The PEG ratio is a ratio of two ...

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the ...